
|Articles|March 20, 2006
FDA approves Bausch & Lomb 100 Hz Zyoptix laser
Bausch & Lomb announces that the FDA has approved the 217z100 Zyoptix excimer laser. The 100 Hz laser operates at twice the speed of the company?s current system in both standard and custom treatment modes.
Advertisement
Bausch & Lomb announces that the FDA has approved the 217z100 Zyoptix excimer laser. The 100 Hz laser operates at twice the speed of the company's current system in both standard and custom treatment modes.
The laser - with its unique combination of beam diameters and laser speed - is expected to be commercially available in July, along with an upgrade path to allow current users to access the faster technology.
For more information, visit Bausch & Lomb at Booth 426.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
3
Study links alcohol consumption to earlier advanced presbyopia in men
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5





















